Syndecan-4 functionalization reduces the thrombogenicity of engineered vascular biomaterials

HIGHLIGHTS

  • who: Yidi Wu from the Department of Plastic and Reconstructive Surgery, Medical Center Boulevard, Wake Forest University School of Medicine, Winstonu2011Salem, NC, USA have published the research work: Syndecan-4 Functionalization Reduces the Thrombogenicity of Engineered Vascular Biomaterials, in the Journal: (JOURNAL)
  • what: In this study the hemocompatibility of PFC_SYN4 was evaluated and compared with nonfunctionalized PFC electrospun collagen ePTFE and bovine pericardial patch (BPV). The aim of this study was to functionalize a compliance-matched vascular graft material, PFC, with heparan sulfate containing syndecan-4 (PFC_SYN4) and demonstrate improvement in the non-thrombogenic property . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?